Gary Rafaloff
@grafaloff
Followers
687
Following
784
Media
22
Statuses
662
Entrepreneur, business man, family man, sports fan. Parkinson's advocate to advance research and find the cure.
New Jersey
Joined April 2013
2024 report on #Parkinsons drug therapies in the clinical trial pipeline is published Thanks to @InnovationFixer @SueBCal1 @grafaloff @kenpitzer650 @bkfiske & the research team at @CureParkinsonsT And oooh, nice pie chart, instead of that ugly bulls eye https://t.co/Lo7NfH2RfY
2
16
53
Will someone please ask Trump the very simple question "what are black and Hispanic jobs"? #Debates2024 #DebateNight
0
0
0
Another super morning at @WorldPDCongress! First up, Professor @basbloem spoke about the importance of using technology to track progression in Parkinson’s and why we should be moving towards personalised outcomes for patients.
3
5
28
...and one (38.38) on the drug development pipeline for #Parkinsons (by @InnovationFixer, @SueBCal1, @grafaloff, @bkfiske, @MichaelJFoxOrg & the research team at @CureParkinsonsT). See the latest report at @journal_PD: https://t.co/layV8A6fdm
1
1
5
@CureParkinsonsT Also a very kind mention of the annual drug development pipeline for #Parkinsons report (McFarthing et al - https://t.co/layV8A6fdm)
@InnovationFixer @SueBCal1 @grafaloff @bkfiske @MichaelJFoxOrg @CureParkinsonsT
2
1
3
We want to change the future for those living with Parkinson’s and those yet to be diagnosed - to change attitudes and raise awareness, and to speed up progress in the search for the cure: https://t.co/uRzi4gWQ8g
#ChangeTheFuture #ParkinsonsTogether
1
5
18
What is the latest update on #Parkinsons drug therapies in the clinical trial pipeline? Explore new findings published in the ‘Journal of Parkinson’s Disease’: https://t.co/sRosnyPKas
0
2
4
(2/2) The committee, comprising of over 20 world-leading Parkinson’s researchers, will then prioritise the most promising treatments to move them into clinical trial for Parkinson’s. To discover more about the impact of our iLCT programme visit: https://t.co/OTDKAEu0Vo
0
3
8
(1/2) The dedicated International Linked Clinical Trials (iLCT) committee will meet this weekend at Cumberland Lodge, Windsor to evaluate and rank a selection of potentially disease-modifying treatments for Parkinson’s. #ILCT #CureParkinsons #ParkinsonsResearch
2
6
23
(2/2) The main aim of the iLCT programme is to repurpose or reposition existing treatments that have the potential to modify Parkinson’s and progress them into clinical trial for Parkinson’s. To find out more about our iLCT programme head to: https://t.co/XQCIumf7qW
1
3
8
(1/2) In 2012 Cure Parkinson’s set up the International Linked Clinical Trials (iLCT) programme to speed up the search for potential treatments for Parkinson’s. #ILCT #CureParkinsons #ParkinsonsResearch
2
5
15
New report from @sahar__yassine @MahmoodHacan & colleagues identifies #Parkinsons subtypes based on resting-state electroencephalography signatures that may provide a more accurate prognosis in patients & help to stratify subgroups in clinical trials https://t.co/mohBIcCvJS
2
5
19
Our 4th annual #Parkinsons disease Clinical Trial Pipeline - 2023 update report is now available prepublished at the Journal of Parkinsons Disease https://t.co/qJB6Ub5vms
@AGKootenay
journals.sagepub.com
Background: Since 2020, annual reports on the clinical development of new drug-based therapies for the neurodegenerative condition of Parkinson’s disease (PD) h...
0
0
0
Our 2023 #Parkinsons clinical trial pipeline update is now available
journals.sagepub.com
Background: Since 2020, annual reports on the clinical development of new drug-based therapies for the neurodegenerative condition of Parkinson’s disease (PD) h...
The 2023 update of the #Parkinsons disease drug therapies in the clinical trial pipeline is now available at @journal_PD - from @InnovationFixer @SueBCal1 @grafaloff @bkfiske @MichaelJFoxOrg & the research team at @CureParkinsonsT
https://t.co/layV8A6fdm
0
1
5
A fantastic resource for #Parkinsons
Wow! An amazing #openaccess resource from the @MichaelJFoxOrg - their quarterly #Parkinsons Priority Therapeutic Clinical Pipeline Report is now openly available on @ZENODO_ORG
https://t.co/6zYW4IV9jv
0
1
3
Digital Health Technologies (DHTs) for Drug Development
fda.gov
Digital Health Technologies (DHTs) for Drug Development
0
0
1
What goes up and what down: 8 Parkinson's microbiome studies. 'Increased Enterobacteriaceae in 4; decreased Prevotellaceae in 5. Lactobacillaceae up in 4, down in 1.' This is why simply taking a random 'probiotic' could be good or could be bad in my view. https://t.co/rbkcUdZYmP
3
9
21
We couldn't ask for a better advancement in open research. Let's hope all other organizations follow this path! Congratulations @CureParkinsonsT
Comments & critiques are welcomed And for those not keen on the heavy science, the lovely comm.s team at @CureParkinsonsT have also provided a lay summary of the research & justification: https://t.co/9PWCCNPhIf
0
0
2
So honored to be a co-author and member of the great team that won the "Best Clinical Research" paper published in the Journal of Parkinson's Disease (2020-2021). Thank you JPD for the award! @SueBCal1 @ScienceofPD @InnovationFixer @HelenMatthewsQ
We are proud to announce the 2022 winners of the #ParkinsonPrize: Thomas Beach and Charles Adler win for best basic research paper, and Simon Stott wins for the best clinical research paper published in our 2020-21 content. Read more: https://t.co/ChoIQWa82f.
@basbloem @kalialabs
0
0
2
We are proud to announce the 2022 winners of the #ParkinsonPrize: Thomas Beach and Charles Adler win for best basic research paper, and Simon Stott wins for the best clinical research paper published in our 2020-21 content. Read more: https://t.co/ChoIQWa82f.
@basbloem @kalialabs
1
6
26